Royal Bank of Canada
HOWL icon

Royal Bank of Canada’s Werewolf Therapeutics HOWL Stock Holding History

Royal Bank of Canada’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-62
Closed – – 7371
2025
Q4 		$0 Sell
62
-744
-92% -$905 ﹤0.01% 7348
2025
Q3 		$1K Sell
806
-9,737
-92% -$13.3K ﹤0.01% 6987
2025
Q2 		$11K Buy
10,543
+7,764
+279% +$7.99K ﹤0.01% 6450
2025
Q1 		$3K Sell
2,779
-597
-18% -$782 ﹤0.01% 6487
2024
Q4 		$4K Buy
3,376
+129
+4% +$263 ﹤0.01% 6577
2024
Q3 		$7K Buy
3,247
+51
+2% +$116 ﹤0.01% 6426
2024
Q2 		$8K Buy
3,196
+3,154
+7,510% +$15.1K ﹤0.01% 6415
2024
Q1 		$0 Buy
+42
New +$245 ﹤0.01% 7245
2023
Q4 		– Sell
-335
Closed -$1K – 7316
2023
Q3 		$1K Buy
+335
New +$923 ﹤0.01% 6893
2023
Q2 		– Sell
-2
Closed – – 7411
2023
Q1 		$0 Hold
2
– – ﹤0.01% 7239
2022
Q4 		$0 Sell
2
-385
-99% -$1.01K ﹤0.01% 7425
2022
Q3 		$2K Buy
387
+154
+66% +$836 ﹤0.01% 7023
2022
Q2 		$1K Sell
233
-1,389
-86% -$6.34K ﹤0.01% 7128
2022
Q1 		$7K Sell
1,622
-4,058
-71% -$28.4K ﹤0.01% 7108
2021
Q4 		$68K Buy
5,680
+4,884
+614% +$73.7K ﹤0.01% 6195
2021
Q3 		$14K Buy
796
+277
+53% +$4.73K ﹤0.01% 6837
2021
Q2 		$9K Buy
+519
New +$7.11K ﹤0.01% 6911

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada's HOWL Position: Q1 2026 in Review

Royal Bank of Canada sold out of Werewolf Therapeutics (HOWL) in Q1 2026, closing a stake of 62 shares.

Royal Bank of Canada first reported a position in HOWL in Q2 2021 and held it in 17 quarters. The position peaked at $68K in Q4 2021. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Royal Bank of Canada reported no remaining Werewolf Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 62 Werewolf Therapeutics shares in Q1 2026.
  • Royal Bank of Canada first reported a position in Werewolf Therapeutics in Q2 2021 and held it in 17 quarters.
  • Royal Bank of Canada's Werewolf Therapeutics position peaked at $68K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.